NEW DATABASE OF POTENTIAL DRUG COMPOUNDS TO AID DESIGN OF AIDS AND CANCER TREATMENTS
Dr. Omoshile Clement, the Catalyst Product Manager at Accelrys, comments, “The new release of the Catalyst/NCI2000 database offers an unparalleled opportunity for drug discovery in an area desperate for new therapeutics. With few effective treatments available to fight diseases such as AIDS and cancer, this database will be of enormous benefit to commercial and academic researchers. I expect it to result in significant advancements in pharmacophore design of such new drugs.”
About Catalyst and the Catalyst/NCI2000 database
Catalyst is Accelrys’ leading rational drug design software. It provides a sophisticated environment for pharmacophore modeling and is used by over 130 pharmaceutical and biotech companies around the world.
The Catalyst/NCI2000 database is an important source of comprehensive knowledge of potential drug compounds for academic and commercial researchers designing, identifying, and evaluating new therapeutic candidates.
Most read news
Organizations
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.